DelveInsight's Dermatological Drugs Market Insights report provides the current and forecast market analysis, individual ...

Lupin’s revenue was largely in-line with our estimates (+2.3% ... and GLP-1 launch in India in 2026E will drive growth. We ...

Now, the community is coming together to show support for the victim’s family following the tragic loss. A make-shift ...

As the industry continue to grow, more players are entering the market. What is the status of the CDMO market landscape in India? How Lupin is planning to use this trend as a growth opportunity? India ...

CEO Vinita Gupta stated that Lupin expects to maintain a quarterly range of $220-230 million for its US business, driven by ...

A memorial is growing in O’Fallon, Missouri, for a little girl who will never get to grow old. Authorities told First Alert 4 ...

Treatment MarketThe global urinary tract infection (UTI) treatment market is poised for consistent growth, with an estimated ...

Ramesh Swaminathan, Global CFO of Lupin discusses the impact of Trump's win on the Indian pharmaceutical sector. Growing ...

Lupin Limited delivered a strong financial performance for the second quarter, surpassing market expectations. Net profit for ...

In August 2023, BD received FDA clearance for its BD Respiratory Viral Panel (RVP) for the BD MAXTM System. This innovative single molecular diagnostic combination test swiftly identified and ...

For the quarter ended September, JSPL's steel sales volumes fell 11% quarter-on-quarter to 1.85 million tons, driven largely by a maintenance shutdown at its Raigarh plant. Citi is also concerned ...

State-owned NHPC on Thursday reported a 37 per cent fall in consolidated net profit to Rs 1,069.28 crore in the September ...